Active Ingredient
Salicylic Acid 4%
Nekvnro Psoriasis
FDA Label NDC 84844-001
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Guoyu Trading Co., Ltd. for the product Nekvnro Psoriasis (NDC 84844-001). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, use, do not use, when using, stop use, ask doctor, keep oot of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Purpose
Psoriasis and Seborrheic Dermatitis
Use
relieves and helps prevent recurrence of:
■itching
■irritation
■redness
■flaking
■scaling due to psoriasis and seborrheic dermatitis
Do Not Use
●on children under 2 years of age unless directedby a doctor
●Avoid contact with eyes.
When Using
this product
■avoid contact with eyes. If contact occurs, rinse thoroughly with water.
Stop Use
condition worsens or does not improve after regular use.
Ask Doctor
if condition worsens or does not improve after regular use.
Keep Oot Of Reach Of Children
If swallowed get medical help or contact a Poison Center right away.
Directions
apply twice a day or as needed.
Other Information
store at room temperature.
Inactive Ingredients
Borneol, Cetyl Alcohol, Dimethicone, Glyceryl 1-stearate, Menthol,Nifedipine, etc.
Principal Display Panel
1 (Label1)
2 (Label2)
3 (Label3)
4 (Label4)
5 (Label5)
6 (Label6)
7 (Label7)
8 (Label8)
9 (Label9)
10 (Label10)
* Please review the disclaimer below.
